62 related articles for article (PubMed ID: 28911813)
1. Functional dynamics in cyclic nucleotide signaling and amyloid inhibition.
VanSchouwen B; Ahmed R; Milojevic J; Melacini G
Biochim Biophys Acta Proteins Proteom; 2017 Nov; 1865(11 Pt B):1529-1543. PubMed ID: 28911813
[TBL] [Abstract][Full Text] [Related]
2. Understanding cAMP-dependent allostery by NMR spectroscopy: comparative analysis of the EPAC1 cAMP-binding domain in its apo and cAMP-bound states.
Mazhab-Jafari MT; Das R; Fotheringham SA; SilDas S; Chowdhury S; Melacini G
J Am Chem Soc; 2007 Nov; 129(46):14482-92. PubMed ID: 17973384
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of cAMP Partial Agonism in Protein Kinase G (PKG).
VanSchouwen B; Selvaratnam R; Giri R; Lorenz R; Herberg FW; Kim C; Melacini G
J Biol Chem; 2015 Nov; 290(48):28631-41. PubMed ID: 26370085
[TBL] [Abstract][Full Text] [Related]
4. Mutations of PKA cyclic nucleotide-binding domains reveal novel aspects of cyclic nucleotide selectivity.
Lorenz R; Moon EW; Kim JJ; Schmidt SH; Sankaran B; Pavlidis IV; Kim C; Herberg FW
Biochem J; 2017 Jul; 474(14):2389-2403. PubMed ID: 28583991
[TBL] [Abstract][Full Text] [Related]
5. Parallel Allostery by cAMP and PDE Coordinates Activation and Termination Phases in cAMP Signaling.
Krishnamurthy S; Tulsian NK; Chandramohan A; Anand GS
Biophys J; 2015 Sep; 109(6):1251-63. PubMed ID: 26276689
[TBL] [Abstract][Full Text] [Related]
6. Fractionation factors reveal hidden frustration in an ancient allosteric module.
VanSchouwen B; Della Libera L; Melacini G
J Chem Phys; 2023 Mar; 158(12):121101. PubMed ID: 37003757
[TBL] [Abstract][Full Text] [Related]
7. Capturing cyclic nucleotides in action: snapshots from crystallographic studies.
Rehmann H; Wittinghofer A; Bos JL
Nat Rev Mol Cell Biol; 2007 Jan; 8(1):63-73. PubMed ID: 17183361
[TBL] [Abstract][Full Text] [Related]
8. Structures of inactive CRP species reveal the atomic details of the allosteric transition that discriminates cyclic nucleotide second messengers.
Seok SH; Im H; Won HS; Seo MD; Lee YS; Yoon HJ; Cha MJ; Park JY; Lee BJ
Acta Crystallogr D Biol Crystallogr; 2014 Jun; 70(Pt 6):1726-42. PubMed ID: 24914983
[TBL] [Abstract][Full Text] [Related]
9. cAMP-dependent allostery and dynamics in Epac: an NMR view.
Selvaratnam R; Akimoto M; VanSchouwen B; Melacini G
Biochem Soc Trans; 2012 Feb; 40(1):219-23. PubMed ID: 22260694
[TBL] [Abstract][Full Text] [Related]
10. Tapping the translation potential of cAMP signalling: molecular basis for selectivity in cAMP agonism and antagonism as revealed by NMR.
Boulton S; Akimoto M; VanSchouwen B; Moleschi K; Selvaratnam R; Giri R; Melacini G
Biochem Soc Trans; 2014 Apr; 42(2):302-7. PubMed ID: 24646235
[TBL] [Abstract][Full Text] [Related]
11. Identification of lead BAY60-7550 analogues as potential inhibitors that utilize the hydrophobic groove in PDE2A: a molecular dynamics simulation study.
Kumar J; Umar T; Kausar T; Mobashir M; Nayeem SM; Hoda N
J Mol Model; 2017 Jan; 23(1):7. PubMed ID: 27966018
[TBL] [Abstract][Full Text] [Related]
12. Collagen stimulation of platelets induces a rapid spatial response of cAMP and cGMP signaling scaffolds.
Margarucci L; Roest M; Preisinger C; Bleijerveld OB; van Holten TC; Heck AJ; Scholten A
Mol Biosyst; 2011 Jul; 7(7):2311-9. PubMed ID: 21597619
[TBL] [Abstract][Full Text] [Related]
13. Structure and rearrangements in the carboxy-terminal region of SpIH channels.
Flynn GE; Black KD; Islas LD; Sankaran B; Zagotta WN
Structure; 2007 Jun; 15(6):671-82. PubMed ID: 17562314
[TBL] [Abstract][Full Text] [Related]
14. Cyclic nucleotide imaging and cardiovascular disease.
Berisha F; Nikolaev VO
Pharmacol Ther; 2017 Jul; 175():107-115. PubMed ID: 28216026
[TBL] [Abstract][Full Text] [Related]
15. Solution NMR structure and inhibitory effect against amyloid-β fibrillation of Humanin containing a d-isomerized serine residue.
Alsanousi N; Sugiki T; Furuita K; So M; Lee YH; Fujiwara T; Kojima C
Biochem Biophys Res Commun; 2016 Sep; 477(4):647-653. PubMed ID: 27349871
[TBL] [Abstract][Full Text] [Related]
16. Investigating the amyloid-beta enhancing effect of cGMP in neuro2a cells.
Calcagno E; Caudano F; Passalacqua M; Pronzato MA; Fedele E; Ricciarelli R
Mech Ageing Dev; 2017 Sep; 166():1-5. PubMed ID: 28789837
[TBL] [Abstract][Full Text] [Related]
17. Molecular modeling studies on CNG channel from bovine retinal rod: a structural model of the cyclic nucleotide-binding domain.
Punta M; Cavalli A; Torre V; Carloni P
Proteins; 2003 Aug; 52(3):332-8. PubMed ID: 12866047
[TBL] [Abstract][Full Text] [Related]
18. Mathematical Modelling of Nitric Oxide/Cyclic GMP/Cyclic AMP Signalling in Platelets.
Kleppe R; Jonassen I; Døskeland SO; Selheim F
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29462984
[TBL] [Abstract][Full Text] [Related]
19. A cyclic peptide inhibitor of apoC-II peptide fibril formation: mechanistic insight from NMR and molecular dynamics analysis.
Griffin MD; Yeung L; Hung A; Todorova N; Mok YF; Karas JA; Gooley PR; Yarovsky I; Howlett GJ
J Mol Biol; 2012 Mar; 416(5):642-55. PubMed ID: 22244853
[TBL] [Abstract][Full Text] [Related]
20. Plasma clearance rates and renal clearance of 3H-labeled cyclic AMP and 3H-labeled cyclic GMP in the dog.
Blonde L; Wehmann RE; Steiner AL
J Clin Invest; 1974 Jan; 53(1):163-72. PubMed ID: 4357610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
